Latest Breaking News On - அதிர்ச்சி அலை மருத்துவ இன்க் - Page 3 : comparemela.com

Mid-Day Market Update: 3D Systems Rises After Upbeat Earnings; Larimar Therapeutics Shares Slide

Mid-Day Market Update: 3D Systems Rises After Upbeat Earnings; Larimar Therapeutics Shares Slide
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.

United statesCity ofUnited kingdomSan franciscoRaphael bosticPatrick harkerMary dalyJohns hopkins universityFederal reserve bankShockwave medical incAlset ehome international incRekor systems incAlset ehome internationalFuturefuel corpTransdigm group incorporatedFerro corporation

Adam Maeder

Shockwave Medical Inc (NSDQ: SWAV) first-quarter FY21 sales more than double to $31.9 million beating the Wall Street consensus of $29.9 million. The growth was primarily driven by the launch of the coronary product, Shockwave C, in the U.S. in February and increased adoption of. Read More. Don t Miss Any Updates! News Directly in Your Inbox Subscribe to:

Shockwave medical incWall streetஅதிர்ச்சி அலை மருத்துவ இன்க்சுவர் தெரு

(SWAV) - Recap: ShockWave Medical Q1 Earnings

Price action over last quarter: Up 13.48% Company Description ShockWave Medical Inc a medical device company focused on developing and commercializing products intended to transform the way calcified cardiovascular disease is treated. Its intravascular lithotripsy technology is used in the treatment of calcified plaque. Geographically, the company generates its revenue from the United States.

United statesShockwave medical incCompany descriptionShockwave medicalWave medical incஒன்றுபட்டது மாநிலங்களில்அதிர்ச்சி அலை மருத்துவ இன்க்நிறுவனம் விளக்கம்அதிர்ச்சி அலை மருத்துவஅலை மருத்துவ இன்க்

iShares NASDAQ Biotechnology Index Fund (NASDAQ:IBB), (ABCL) - The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings

iShares NASDAQ Biotechnology Index Fund (NASDAQ:IBB), (ABCL) - The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.

United statesStrongbridge biopharmaCellular therapies incMatinas biopharma holdings incCyclacel pharmaceuticals incCastle biosciences incOpiant pharmaceuticals incBiotechnology corporationInovio pharmaceuticals incAmicus therapeutics incSio gene therapies incHalozyme therapeutics incAthenex incFate therapeutics incPfizer incLyra therapeutics inc

iShares NASDAQ Biotechnology Index Fund (NASDAQ:IBB), ABIOMED, Inc (NASDAQ:ABMD) - The Daily Biotech Pulse: Clinical Setback For Adverum, Galera Posts Data Readout, Moderna To Invest In Vaccine Manufacturing, Decision Day For Ardelyx

ShockWave Medical, Inc. (NASDAQ: SWAV) Verastem, Inc. (NASDAQ: VSTM) Down In The Dumps Akoya Biosciences, Inc. (NASDAQ: AKYA) Decibel Therapeutics, Inc. (NASDAQ: DBTX) IRadimed Corporation (NASDAQ: IRMD) Lucira Health, Inc. (NASDAQ: LHDX) Mesoblast Limited (NASDAQ: MESO) Protara Therapeutics, Inc. (NASDAQ: TARA) PTC Therapeutics, Inc. (NASDAQ: PTCT) Stocks In Focus Adverum Shares Sink On Serious Adverse Event Adverum Biotechnologies, Inc. (NASDAQ: ADVM) announced a suspected unexpected serious adverse reaction of hypotony, which is clinically relevant decrease in ocular pressure, in its INFINITY clinical trial evaluating ADVM-022 gene therapy for the treatment of diabetic macular edema. This event occurred 30 weeks after randomization in one patient treated with a single intravitreal injection of the high dose of ADVM-022 who has developed hypotony, with panuveitis and loss of vision in the treated eye.

United statesAuburn hillsDominican republicProtalix bioAxonics incJabil incAmerican society of gene cell therapyArdelyx incBiogen incNuvasive incTherapeutics incCelcuity incModerna incMimedx group incGalera therapeutics incMacrogenics inc